What is the recommended dose of propranolol (beta blocker) for migraine prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Migraine Prophylaxis

The recommended dose of propranolol for migraine prophylaxis is 160-240 mg once daily, with an initial starting dose of 80 mg once daily. 1, 2

Dosing Guidelines

Initial Dosing and Titration

  • Start with 80 mg propranolol extended-release capsules once daily 2
  • Gradually increase the dose at intervals of several days to weeks until optimal response is achieved 2
  • The usual effective dose range is 160-240 mg once daily 2
  • According to the American Academy of Neurology, propranolol is effective at doses of 120-240 mg daily for migraine prophylaxis 1

Duration of Treatment

  • If a satisfactory response is not obtained within 4-6 weeks after reaching the maximum dose, propranolol therapy should be discontinued 2
  • When discontinuing treatment, gradually taper the dose over several weeks to prevent withdrawal symptoms 1, 2
  • Continue effective prophylactic treatment for at least 3-6 months before attempting discontinuation 1

Clinical Considerations

Efficacy

  • Propranolol is recommended as a first-line agent for migraine prophylaxis by the American Academy of Neurology 1
  • While some older studies suggest that lower doses (around 40-80 mg daily) may be effective for some patients 3, 4, the most current guidelines and FDA labeling support the higher dose range of 160-240 mg daily for optimal efficacy 1, 2

Formulation Considerations

  • Extended-release formulations allow for once-daily dosing, improving adherence
  • When switching from immediate-release to extended-release formulations, retitration may be necessary as they have different kinetics and produce lower blood levels 2
  • Extended-release propranolol should not be considered a simple mg-for-mg substitute for immediate-release tablets 2

Monitoring and Follow-up

  • Evaluate treatment response after 4-6 weeks 1
  • Monitor for common side effects such as fatigue, dizziness, and sleep disturbances
  • If discontinuing treatment, taper gradually over several weeks to prevent rebound headaches or withdrawal symptoms 1, 2

Common Pitfalls and Caveats

  • Inadequate dose: Starting with too low a dose and failing to titrate to the effective range (160-240 mg) may result in treatment failure
  • Insufficient duration of treatment: Migraine prophylaxis requires consistent treatment for at least 3-6 months before attempting discontinuation 1
  • Abrupt discontinuation: Always taper propranolol gradually to prevent withdrawal symptoms or rebound headaches 1, 2
  • Inadequate follow-up: Regular assessment of efficacy and side effects is essential to optimize treatment
  • Contraindications: Be aware of contraindications including asthma, bradycardia, heart block, and certain cardiac conditions

Alternative Options

If propranolol is ineffective or poorly tolerated, other evidence-based options for migraine prophylaxis include:

  • Timolol (20-30 mg/day)
  • Amitriptyline (30-150 mg/day)
  • Topiramate (100 mg/day)
  • Divalproex sodium (500-1500 mg/day)
  • CGRP antagonists for patients with inadequate response to traditional preventives 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.